Home » Stocks » West Pharmaceutical Services

West Pharmaceutical Services, Inc. (WST)

Stock Price: $279.25 USD -2.68 (-0.95%)
Updated Oct 26, 2020 3:21 PM EDT - Market open

Stock Price Chart

Key Info

Market Cap 20.62B
Revenue (ttm) 2.04B
Net Income (ttm) 311.70M
Shares Out 73.84M
EPS (ttm) 4.13
PE Ratio 67.62
Forward PE 64.52
Dividend $0.64
Dividend Yield 0.23%

Stock Quote

Trading Day Oct 26, 2020
Last Price $279.25
Previous Close $281.93
Change ($) -2.68
Change (%) -0.95%
Day's Open 278.97
Day's Range 278.64 - 282.72
Day's Volume 250,947
52-Week Range 124.53 - 303.14

More Stats

Market Cap 20.62B
Enterprise Value 20.43B
Earnings Date (est) Feb 18, 2021
Ex-Dividend Date n/a
Shares Outstanding 73.84M
Float 73.35M
EPS (basic) 4.23
EPS (diluted) 4.13
FCF / Share 3.73
Dividend $0.64
Dividend Yield 0.23%
Earnings Yield 1.48%
FCF Yield 1.34%
Payout Ratio 15.10%
Shares Short 683,559
Short Ratio 1.25
Short % of Float 0.93%
Beta 1.13
PE Ratio 67.62
Forward PE 64.52
P/FCF Ratio 74.74
PS Ratio 10.12
PB Ratio 12.11
Revenue 2.04B
Operating Income 362.90M
Net Income 311.70M
Free Cash Flow 275.90M
Net Cash 193.90M
Net Cash / Share 2.63
Gross Margin 29.73%
Operating Margin 17.81%
Profit Margin 15.30%
FCF Margin 13.54%
ROA 9.70%
ROE 19.44%
ROIC 22.00%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (6)

Buy 3
Overweight 0
Hold 2
Underweight 0
Sell 1

Analyst Consensus: Overweight

Price Target

(2.06% upside)
Current: $279.25
Target: 285.00
*Average 12-month price target from 4 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Revenue Growth7.13%7.4%5.96%7.81%-1.52%3.87%8.05%6.21%7.93%-
Gross Profit606545513501456448435388339318
Operating Income29424222819512918216213611090.70
Net Income24220715114495.6012711280.7075.5065.30
Shares Outstanding74.0073.9073.9073.3072.0070.9069.6068.1067.3066.60
Earnings Per Share3.212.741.991.911.301.751.571.151.080.95
EPS Growth17.15%37.69%4.19%46.92%-25.71%11.46%36.52%6.48%14.29%-
Dividend Per Share0.610.570.530.490.450.410.390.370.350.33
Dividend Growth7.02%7.55%8.16%8.89%9.76%6.49%5.48%5.8%6.15%-
Operating Cash Flow367289263219212183221187131138
Capital Expenditures-126-105-131-170-132-112-152-131-95.40-71.10
Free Cash Flow24118413349.2080.8071.0068.6056.1035.3067.20
Cash & Equivalents439337236203275255230174118110
Total Debt329196197229298336374412349358
Net Cash / Debt11014138.90-25.60-23.60-80.20-144-237-231-248
Book Value1,5731,3961,2801,1181,024957906729655626
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name West Pharmaceutical Services, Inc.
Country United States
Employees 8,200
CEO Eric Mark Green

Stock Information

Ticker Symbol WST
Stock Exchange New York Stock Exchange
Sector Healthcare
Industry Medical Instruments & Supplies
Unique Identifier NYSE: WST


West Pharmaceutical Services manufactures and sells containment and delivery systems for injectable drugs and healthcare products in the United States, Germany, Ireland, France, Other European countries, and internationally. The company operates through two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, and washing and sterilization processes and services to enhance the quality of packaging components. It also provides drug containment solutions, including Crystal Zenith, a cyclic olefin polymer in the form of vials, syringes, and cartridges; and self-injection devices, as well as a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of components and devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. This segment serves pharmaceutical, diagnostic, and medical device companies. It distributes its products through its sales force and distribution network, as well as contract sales agents and regional distributors. The company was founded in 1923 and is headquartered in Exton, Pennsylvania.